177 related articles for article (PubMed ID: 22441000)
1. Successful long-term treatment of Cushing disease with mifepristone (RU486).
Basina M; Liu H; Hoffman AR; Feldman D
Endocr Pract; 2012; 18(5):e114-20. PubMed ID: 22441000
[TBL] [Abstract][Full Text] [Related]
2. BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY.
Geer EB; Shafiq I; Gordon MB; Bonert V; Ayala A; Swerdloff RS; Katznelson L; Lalazar Y; Manuylova E; Pulaski-Liebert KJ; Carmichael JD; Hannoush Z; Surampudi V; Broder MS; Cherepanov D; Eagan M; Lee J; Said Q; Neary MP; Biller BMK
Endocr Pract; 2017 Aug; 23(8):962-970. PubMed ID: 28614003
[TBL] [Abstract][Full Text] [Related]
3. Advances in the Medical Treatment of Cushing Disease.
Tritos NA; Biller BMK
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):401-412. PubMed ID: 32741479
[TBL] [Abstract][Full Text] [Related]
4. Medical treatment of Cushing's syndrome: glucocorticoid receptor antagonists and mifepristone.
Castinetti F; Conte-Devolx B; Brue T
Neuroendocrinology; 2010; 92 Suppl 1():125-30. PubMed ID: 20829633
[TBL] [Abstract][Full Text] [Related]
5. Medical Management of Cushing Disease.
Tritos NA; Biller BMK
Neurosurg Clin N Am; 2019 Oct; 30(4):499-508. PubMed ID: 31471057
[TBL] [Abstract][Full Text] [Related]
6. Mifepristone: treatment of Cushing's syndrome.
Sartor O; Cutler GB
Clin Obstet Gynecol; 1996 Jun; 39(2):506-10. PubMed ID: 8734015
[TBL] [Abstract][Full Text] [Related]
7. Mifepristone Treatment of Cushing's Syndrome in a Pediatric Patient.
Banerjee RR; Marina N; Katznelson L; Feldman BJ
Pediatrics; 2015 Nov; 136(5):e1377-81. PubMed ID: 26459648
[TBL] [Abstract][Full Text] [Related]
8. Long-term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia.
Newfield RS; Spitz IM; Isacson C; New MI
Clin Endocrinol (Oxf); 2001 Mar; 54(3):399-404. PubMed ID: 11298094
[TBL] [Abstract][Full Text] [Related]
9. Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH).
Cohan P; East HE; Galati SJ; Mercado JU; Lim PJ; Lamerson M; Smith JJ; Peters AL; Yuen KCJ
J Clin Endocrinol Metab; 2019 Dec; 104(12):6279-6290. PubMed ID: 31112270
[TBL] [Abstract][Full Text] [Related]
10. New prospects for drug treatment in Cushing disease.
Barahona Constanzo MJ; del Pozo Picó C
Endocrinol Nutr; 2012 Dec; 59(10):599-605. PubMed ID: 23036936
[TBL] [Abstract][Full Text] [Related]
11. Medical management of Cushing disease.
Gross BA; Mindea SA; Pick AJ; Chandler JP; Batjer HH
Neurosurg Focus; 2007; 23(3):E10. PubMed ID: 17961023
[TBL] [Abstract][Full Text] [Related]
12. Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486).
Chu JW; Matthias DF; Belanoff J; Schatzberg A; Hoffman AR; Feldman D
J Clin Endocrinol Metab; 2001 Aug; 86(8):3568-73. PubMed ID: 11502780
[TBL] [Abstract][Full Text] [Related]
13. Cushing's disease.
Tritos NA; Biller BM
Handb Clin Neurol; 2014; 124():221-34. PubMed ID: 25248590
[TBL] [Abstract][Full Text] [Related]
14. Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases.
Chang AY; Mirfakhraee S; King EE; Mercado JU; Donegan DM; Yuen KC
Clin Med Insights Endocrinol Diabetes; 2021; 14():1179551421994102. PubMed ID: 33746521
[TBL] [Abstract][Full Text] [Related]
15. How best to monitor the specific side effects of medical treatments of Cushing's disease.
Castinetti F
Best Pract Res Clin Endocrinol Metab; 2022 Dec; 36(6):101718. PubMed ID: 36435719
[TBL] [Abstract][Full Text] [Related]
16. Medical treatment of Cushing disease: new targets, new hope.
Fleseriu M
Endocrinol Metab Clin North Am; 2015 Mar; 44(1):51-70. PubMed ID: 25732642
[TBL] [Abstract][Full Text] [Related]
17. Mifepristone: is there a place in the treatment of Cushing's disease?
Carmichael JD; Fleseriu M
Endocrine; 2013 Aug; 44(1):20-32. PubMed ID: 23192246
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological management of Cushing's syndrome: an update.
Dang CN; Trainer P
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1339-48. PubMed ID: 18209872
[TBL] [Abstract][Full Text] [Related]
19. AACE/ACE Disease State Clinical Review: Medical Management of Cushing Disease.
Hamrahian AH; Yuen KC; Hoffman AR;
Endocr Pract; 2014 Jul; 20(7):746-57. PubMed ID: 25057099
[TBL] [Abstract][Full Text] [Related]
20. Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockers.
Fleseriu M; Petersenn S
Pituitary; 2015 Apr; 18(2):245-52. PubMed ID: 25560275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
